(Q36102568)

12 August 2017

1 reference

title

Oncolytic viruses for cancer therapy II. Cell-internal factors for conditional growth in neoplastic cells (English)

1 reference

12 August 2017

1 reference

Stephanie A Campbell

1

1 reference

PubMed ID

15840970

12 August 2017

Matthias Gromeier

series ordinal

2

1 reference

12 August 2017

31 March 2005

1 reference

12 August 2017

1 reference

12 August 2017

28

1 reference

12 August 2017

4

1 reference

12 August 2017

209-215

1 reference

Oncolytic viruses for cancer therapy I. Cell-external factors: virus entry and receptor interaction

12 August 2017

1 reference

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

E1B-deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumors

21 January 2018

1 reference

Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial

21 January 2018

1 reference

A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the Baylor experience).

21 January 2018

1 reference

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors

21 January 2018

1 reference

Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas

21 January 2018

1 reference

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

21 January 2018

1 reference

Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.

21 January 2018

1 reference

Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207.

21 January 2018

1 reference

In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents

21 January 2018

1 reference

Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus

21 January 2018

1 reference

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo

21 January 2018

1 reference

Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma

21 January 2018

1 reference

Reovirus therapy of tumors with activated Ras pathway

21 January 2018

1 reference

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

21 January 2018

1 reference

Intergeneric poliovirus recombinants for the treatment of malignant glioma

21 January 2018

1 reference

Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma

21 January 2018

1 reference

Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers

21 January 2018

1 reference

Interferon-induced protein Mx accumulates in nuclei of mouse cells expressing resistance to influenza viruses.

21 January 2018

1 reference

Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus

21 January 2018

1 reference

Constitutive expression of (2'-5') oligo A synthetase confers resistance to picornavirus infection.

21 January 2018

1 reference

The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis

21 January 2018

1 reference

Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma.

21 January 2018

1 reference

The preferential cytotoxicity of reovirus for certain transformed cell lines

21 January 2018

1 reference

The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus

21 January 2018

1 reference

The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus.

21 January 2018

1 reference

Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection

21 January 2018

1 reference

Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis

21 January 2018

1 reference

Newcastle disease virus (NDV): brief history of its oncolytic strains

21 January 2018

1 reference

Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase

21 January 2018

1 reference

Enhanced antitumor efficacy of a herpes simplex virus mutant isolated by genetic selection in cancer cells

21 January 2018

1 reference

A herpes simplex virus type 1 gamma34.5 second-site suppressor mutant that exhibits enhanced growth in cultured glioblastoma cells is severely attenuated in animals

21 January 2018

1 reference

Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype

21 January 2018

1 reference

Viral transactivating proteins

21 January 2018

1 reference

A novel form of Epstein-Barr virus latency in normal B cells in vivo

21 January 2018

1 reference

Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein

21 January 2018

1 reference

Domains required for in vitro association between the cellular p53 and the adenovirus 2 E1B 55K proteins.

21 January 2018

1 reference

Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?

21 January 2018

1 reference

Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000084010

1 reference

12 August 2017

1 reference

PubMed ID

15840970